1. [Home](https://www.g2.com/)
2. ...
3. [AWS Marketplace Software](https://www.g2.com/categories/aws-marketplace)
4. [Patient Eligibility for Cancer Trials Discussions](https://www.g2.com/products/patient-eligibility-for-cancer-trials/discuss)

[
 ![Patient Eligibility for Cancer Trials](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_80156f2e50fff64360d0ba3befe34052/patient-eligibility-for-cancer-trials.jpg "Patient Eligibility for Cancer Trials")
](/products/patient-eligibility-for-cancer-trials/reviews)

# Patient Eligibility for Cancer Trials Discussions

The "Patient Eligibility for Cancer Trials" solution, available on AWS Marketplace, is designed to streamline the process of matching cancer patients with appropriate clinical trials. By leveraging advanced artificial intelligence and machine learning technologies, this solution automates the pre-screening process, significantly reducing the time and effort required by clinicians to identify suitable trials for their patients. Key Features and Functionality: - Automated Pre-Screening: Utilizes AI to analyze patient medical records and match them against clinical trial eligibility criteria, enhancing efficiency and accuracy. - Integration with Clinical Trial Databases: Connects seamlessly with existing clinical trial registries to access up-to-date information on available trials. - Customizable Matching Parameters: Allows for the adjustment of matching criteria to align with specific patient needs and trial requirements. - User-Friendly Interface: Provides an intuitive dashboard for clinicians to review and manage potential trial matches. Primary Value and Problem Solved: This solution addresses the challenges clinicians face in identifying and enrolling patients in suitable cancer clinical trials. By automating the pre-screening process, it reduces the time required to match patients with trials by approximately 40%, as demonstrated in real-life clinical trial matching tasks. This efficiency not only accelerates patient access to potentially life-saving treatments but also enhances the overall effectiveness of clinical research by facilitating the enrollment of eligible participants.

## Be the first to start the conversation

Get answers from real professionals in the G2 community.